Alonate-P 400 mg/g Oral Paste for Horses and Ponies

Care should be taken to avoid the following practices because they increase
the risk of development of resistance and could ultimately result in ineffective
therapy:
•
over an extended period of time.
•
misadministration of the product, or lack of calibration of the dosing
device (if any).
Suspected clinical cases of resistance to anthelmintics should be further
investigated using appropriate tests (e.g. Faecal Egg Count Reduction Test).
Where the results of the test(s) strongly suggest resistance to a particular
anthelmintic, an anthelmintic belonging to another pharmacological class and
having a different mode of action should be used.
Resistance to pyrantel has been reported in cyathostomes in horses (also
widespread in the USA and Canada). Therefore the use of this product should
be based on local (regional, farm) epidemiological information about
susceptibility of nematodes and recommendations on how to limit further
selection for resistance to anthelmintics.

Special precautions for use in animals
The same syringe should only be used to dose two animals if they are both
healthy and are either running together, or are on the same premises and in
direct contact with each other.

Revised: July 2025
AN: 01008/2025
Special precautions to be taken by the person administering the veterinary
medicinal product to animals
Direct contact with the skin should be avoided.
Wash hands and any other parts of the body which comes into contact with
the product after use.
Avoid handling the product if you know you are hypersensitive to pyrantel